Xiaojian Wang Selected Research

Phosphatidylethanolamine Binding Protein

1/2017	Raf Kinase Inhibitor Protein Preferentially Promotes TLR3-Triggered Signaling and Inflammation.
1/2017	Raf kinase inhibitor protein mediates intestinal epithelial cell apoptosis and promotes IBDs in humans and mice.
1/2013	Silencing of human phosphatidylethanolamine-binding protein 4 enhances rituximab-induced death and chemosensitization in B-cell lymphoma.
2/2007	hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways.
9/2006	Anti-apoptotic hPEBP4 silencing promotes TRAIL-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways.
10/2005	Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaojian Wang Research Topics

Disease

23	Neoplasms (Cancer) 05/2021 - 09/2003
13	Inflammation (Inflammations) 05/2022 - 01/2003
6	Breast Neoplasms (Breast Cancer) 12/2019 - 10/2004
6	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 04/2005
5	Colitis 01/2018 - 01/2016
4	Hypertension (High Blood Pressure) 01/2021 - 10/2009
4	Infections 01/2021 - 12/2007
4	Myocardial Infarction 02/2020 - 02/2010
4	Hypertrophy 02/2020 - 08/2008
4	Cardiomegaly (Heart Hypertrophy) 01/2013 - 08/2008
3	Neoplasm Metastasis (Metastasis) 05/2021 - 06/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 04/2007
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 09/2015
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2017
3	Aortic Dissection 01/2021 - 04/2017
3	Carcinogenesis 11/2020 - 12/2014
3	Pulmonary Arterial Hypertension 01/2020 - 05/2014
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 07/2014
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 01/2016
3	Ischemic Stroke 11/2016 - 12/2009
3	Stroke (Strokes) 07/2016 - 02/2009
3	Adenocarcinoma 04/2007 - 01/2003
2	Wounds and Injuries (Trauma) 04/2022 - 01/2021
2	Bacterial Infections (Bacterial Infection) 01/2022 - 12/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2005
2	Pulmonary Hypertension 01/2022 - 01/2020
2	Atherosclerosis 01/2021 - 07/2010
2	Pathologic Processes 01/2021 - 06/2010
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 02/2020
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2017
2	Pulmonary Embolism 01/2021 - 04/2017
2	Virus Diseases (Viral Diseases) 01/2018 - 12/2016
2	AIDS-Related Complex (ARC) 01/2018 - 10/2017
2	Autoimmune Diseases of the Nervous System 02/2017 - 07/2014
2	Bradycardia 02/2017 - 07/2014
2	Atrial Fibrillation 04/2015 - 09/2008
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2010 - 12/2009
2	Cardiomyopathies (Cardiomyopathy) 08/2008 - 05/2006
2	Leukemia 01/2007 - 01/2005
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2007 - 01/2003
1	Arthritis (Polyarthritis) 04/2022
1	Knee Osteoarthritis 04/2022
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 05/2021
1	COVID-19 04/2021

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
7	Phosphotransferases (Kinase)IBA 01/2021 - 08/2008
6	Phosphatidylethanolamine Binding ProteinIBA 01/2017 - 10/2005
5	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 07/2014
4	Pharmaceutical PreparationsIBA 02/2020 - 04/2011
4	Biological ProductsIBA 01/2020 - 06/2009
4	CytokinesIBA 01/2020 - 01/2018
4	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2010
4	Messenger RNA (mRNA)IBA 01/2020 - 01/2003
4	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2017
3	Therapeutic UsesIBA 04/2022 - 01/2009
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2003
3	Small Interfering RNA (siRNA)IBA 02/2020 - 10/2004
3	LigandsIBA 01/2020 - 09/2006
3	AcidsIBA 01/2018 - 01/2017
3	Dextran SulfateIBA 01/2017 - 01/2016
3	Antihypertensive Agents (Antihypertensives)IBA 07/2016 - 10/2009
3	gambogic acidIBA 04/2011 - 06/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2006 - 10/2004
2	Long Noncoding RNAIBA 01/2022 - 02/2020
2	EnzymesIBA 01/2021 - 01/2018
2	InflammasomesIBA 01/2021 - 01/2021
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 01/2018
2	Uric Acid (Urate)IBA 01/2021 - 07/2016
2	SuperantigensIBA 02/2020 - 05/2007
2	Interferon Type IIBA 01/2020 - 12/2016
2	geniposideIBA 01/2020 - 01/2019
2	PolyphenolsIBA 12/2019 - 01/2016
2	maltohexaoseIBA 01/2019 - 12/2014
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 10/2012
2	InterleukinsIBA 01/2018 - 01/2016
2	Antiviral Agents (Antivirals)IBA 01/2018 - 12/2007
2	Syl930IBA 02/2017 - 07/2014
2	farrerolIBA 11/2016 - 09/2015
2	Growth Differentiation Factor 15IBA 07/2016 - 10/2009
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 12/2009
2	LipopolysaccharidesIBA 12/2014 - 01/2007
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 09/2011 - 10/2009
1	C-Reactive ProteinIBA 05/2022
1	QuercetinIBA 04/2022
1	safranine T (safranin)IBA 04/2022
1	Hematoxylin (Haematoxylon)IBA 04/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2022
1	ProdrugsIBA 01/2022
1	Colistin (Coly-Mycin)FDA Link 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	6-methyladenineIBA 05/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 04/2021
1	rehmannia rootIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021

Therapy/Procedure

11	Therapeutics 01/2022 - 06/2005
3	Drug Therapy (Chemotherapy) 11/2016 - 01/2013
3	Immunotherapy 10/2009 - 04/2007